Mesa Laboratories Stock News

Equities research analysts expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to post earnings per share of $2.03 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates

Mesa Laboratories (NASDAQ:MLAB) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, ValuEngine reports.

Analysts forecast that Mesa Laboratories, Inc. (NASDAQ:MLAB) will post sales of $34.50 million for the current quarter, according to Zacks. Two analysts have issued estimates for Mesa Laboratories’

Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John James Sullivan sold 1,702 shares of the business’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price

Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John James Sullivan sold 8,206 shares of the stock in a transaction on Tuesday, February 25th. The stock was sold at an average price of $267.09, for a t

First Trust Advisors LP purchased a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch

Average weekly trading volume of approximately 657,930 shares

Mesa Laboratories (NASDAQ:MLAB) was upgraded by BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday, BidAskClub reports. Several other e

Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold sold 123 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average pric

Comerica Bank trimmed its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 1.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The

Mesa Laboratories, Inc. (NASDAQ:MLAB) reached a new 52-week high on Friday . The company traded as high as $271.46 and last traded at $270.30, with a volume of 1525 shares. The stock had previously cl

Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John Bradley Schmieder sold 1,800 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $266.46, fo

California Public Employees Retirement System trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 11.0% during the fourth quarter, according to its most recent disclosure with t

New York, Feb. 17, 2020 -- Reportlinker.com announces the release of the report "Sterilization Monitoring Market by End-user, Product, and Geography - Forecast and Analysis.